Nanome became the first VR software company to launch an immersive real-time collaboration platform for scientific discovery in 2015. The software environment accelerates scientific decision making by allowing users to visualize, modify, and simulate biological and chemical compounds, facilitating effective communication of data and integrating with existing computational chemistry workflows. Nanome continues to grow by a partnership with Fujitsu to bring his VR tool in Japan. Source: VR startup in US brings immersive drug design software…"VR startup in US brings immersive drug design software to Japan"
At Novartis, virtual reality is used to understand complex interactions between molecules. It’s a way to facilitate communication between chemist and biologist about drug design and protein’s interactions. Viktor Hornak, an investigator in the Global Discovery Chemistry department at the Novartis Institutes for BioMedical Research (NIBR), is driving an effort to adapt VR tools for use in the drug design process. He and his colleagues recognize a potential for VR to help drug hunters more quickly…"Bringing virtual reality to the lab at Novartis"